About Sarah Hein
Form D filings for March Biosciences from 2023 to 2024 list Sarah Hein as co-founder, chief executive officer and director.
Sarah Hein first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Sarah Hein in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Sarah Hein works with at each company, as listed on that company's latest Form D.
March Biosciences, Inc. · Form D, Oct 22, 2024
TL
Thomas Luby
Director
PO
Peter Olagunju
Director
JP
Joseph Petrosino
Director
MM
Maksim Mamonkin
Executive officer and director